Role of CD133 in colorectal cancer

QR Code

Role of CD133 in colorectal cancer

CD133 is a pentaspan transmembrane glycoprotein of ~120 kDa, which was initially used to identify haematopoietic stem cells and, later on, used for the isolation and study of cancer stem cells in many different types of solid tumour including colorectal cancer. Although CD133 expressing cells are th...

Full description

Bibliographic Details
Main Author:	Ahmed, Tarek Mohamed Abdel Moneim Mohamed Elsaba
Format:	Thesis (University of Nottingham only)
Language:	English
Published:	2011
Subjects:	Transmembrane glycoprotein Cancer stem cells Colorectal cancer Prognostic factor
Online Access:	https://eprints.nottingham.ac.uk/28630/

Similar Items

Human rather than mouse mesenchymal stem cells in 3D co-culture models boost proliferative and migratory characteristics of colorectal cancer cells through paracrine signalling pathways, highlighting species disconnects
by: Lu, M.
Published: (2022)

Tissue resident CD8 T cells subsets: prognostic significance in colorectal cancer
by: Talhouni, Shahd
Published: (2022)

Investigation of the role of CD24 gene in the progression of colorectal cancer
by: Hakami, Zaki
Published: (2021)

Role and regulation of CTEN in colorectal cancer
by: Alfahed, Abdulaziz/AF
Published: (2020)

A Comparison of Continuum and Cell-based Models of Colorectal Cancer
by: Walter, Alexander
Published: (2009)

eIF4A2 is a regulator of hypoxic translation and colorectal tumour cell survival
by: Bolland, Hannah
Published: (2020)

Investigating the role of Cten in metastatic colorectal cancer
by: Thorpe, Hannah
Published: (2016)

Morphological alterations of cultured human colorectal matched tumour and healthy organoids
by: Mohammad, Seyed, et al.
Published: (2018)

Investigating the role of FOSL2 and JUND in the molecular adaptation to hypoxia in colorectal cancer
by: Potgieter, Tammy
Published: (2023)

Tea, Coffee, and Milk Consumption and Colorectal Cancer Risk
by: Green, C., et al.
Published: (2014)

Identification of drug(s) selectively targeting colorectal cancer stem-like cells for differentiation (differentiation therapy)
by: Ahmed, Mehreen
Published: (2020)

Interrogating the genetic profile of sporadic colorectal cancer
by: Fadhil, Wakkas M.
Published: (2019)

Investigating the role of Cut Like Homeobox 1 CUX1 in colorectal cancer progression
by: Rusnita, Dewi
Published: (2024)

Mechanisms and roles of FLYWCH1 in colorectal cancer
by: Onyido, Emenike K.
Published: (2017)

Accelerated carcinogenesis of colorectal cancer
by: Lam, XiuQian
Published: (2021)

The role of HOXA5 in triple-negative breast cancer (TNBC)
by: Mahmoud, Rinad
Published: (2021)

Surgical resection of primary tumour improves aerobic performance in colorectal cancer
by: Williams, John P., et al.
Published: (2014)

Histopathological analysis of CD44 and c-Myc in colorectal cancer
by: Littlewood, Stephanie
Published: (2021)

An investigation into entotic behaviour of breast cancer cells
by: ZAILAN, YASMEEN
Published: (2018)

Investigating the interactions between tumour cells and the non-tumour cellular community in colorectal cancer
by: Susanti, Susanti
Published: (2021)

Anti-tumour efficacy of human mesenchymal stem cell expressing trail on lung cancer cell lines-derived cancer stem cell
by: Shaik M Fakiruddin, Shaik Ahmad Kamal
Published: (2021)

Systematic review of pre-operative exercise in colorectal cancer patients
by: Boereboom, C., et al.
Published: (2016)

Variation in the risk of venous thromboembolism in people with colorectal cancer: a population-based cohort study from England
by: Walker, A.J., et al.
Published: (2014)

Optimisation of Faecal Immunochemical Test (FIT) for symptomatic colorectal cancer diagnosis
by: Bailey, James Alexander
Published: (2024)

Creatinine and myoglobin are poor predictors of anaerobic threshold in colorectal cancer and health
by: Nyasavajjala, Sitaramachandra M., et al.
Published: (2015)

Expression of β-catenin, Ki67 and stroma percentage in colorectal cancer
by: Suanno, Cristina
Published: (2021)

Cost-Effectiveness of an Advance Notification Letter to Increase Colorectal Cancer Screening
by: Cronin, P., et al.
Published: (2013)

Effects of co-loaded doxorubicin and thymoquinone calcium carbonate nanoparticles on MDA MB231 breast cancer stem cells
by: Muibat, Ibiyeye Kehinde
Published: (2019)

Inhibition of HER2 enriches for Jagged1-dependent breast cancer stem cells: role for membrane Jagged1
by: Shah, Deep, et al.
Published: (2018)

The potential role of free chitosan in bone trauma and bone cancer management
by: Tan, M., et al.
Published: (2014)

CD10 inhibits cell motility but expression is associated with advanced stage disease in colorectal cancer
by: Raposo, T.P., et al.
Published: (2018)

Molecular characterisation of the early metastatic phenotype in colorectal cancer
by: Sculthorpe, Declan
Published: (2024)

One-third of patients fail to return to work 1 year after surgery for colorectal cancer
by: Bhalla, Ashish, et al.
Published: (2014)

Studies using the anti-idiotypic monoclonal antibody 105AD7 in patients with advanced and primary colorectal cancer
by: Maxwell-Armstrong, Charles Alan
Published: (1998)

The inter-relationship between p53, survivin and XIAP in colorectal cancer cells response to apoptotic stimuli
by: Atakpa, Isaac
Published: (2024)

Investigate tumour heterogeneity and genetic pathways in colorectal cancer
by: Ham Karim, Hersh Abdul
Published: (2017)

DNA content analysis of colorectal cancer defines a distinct ‘microsatellite and chromosome stable’ group but does not predict response to radiotherapy
by: Fadhil, Wakkas, et al.
Published: (2014)

Unravelling the tumour- and cancer stem cell (CSC)-regulatory roles of miR-3934-5p in human breast cancer
by: Chong, Zhi Xiong
Published: (2024)

High mobility group protein B1 is a predictor of poor survival in ovarian cancer
by: Machado, Lee R, et al.
Published: (2017)

Investigating the role of eIF4A2 in the spatial regulation of metabolic adaptation to hypoxia in colorectal cancer
by: Thornton, Luke
Published: (2023)